Medico — April 2024
-
Demant-chef: Stigende tilskud har hjulpet markedet i USA - men ikke som i Europa https://www.proinvestor.com/investornyt/1147365/demant-chef-stigende-tilskud-har-hjulpet-markedet-i-usa-men-ikke-som-i-europa
-
Demant-chef ser mere aktive ældre løfte markedet i USA https://www.proinvestor.com/investornyt/1147364/demant-chef-ser-mere-aktive-aeldre-lofte-markedet-i-usa
-
GN får sat kursmålet op af Danske Bank der spår pæn organisk vækst i første kvartal https://www.proinvestor.com/investornyt/1147374/gn-far-sat-kursmalet-op-af-danske-bank-der-spar-paen-organisk-vaekst-i-forste-kvartal
-
GN ser frem mod 1. maj med spænding: Resound Nexia gøres klar til VA https://www.proinvestor.com/investornyt/1148285/gn-ser-frem-mod-1-maj-med-spaending-resound-nexia-gores-klar-til-va
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://www.proinvestor.com/investornyt/1148294/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Embla Medical voksede på toplinjen men opkøb og omstrukturering kostede https://www.proinvestor.com/investornyt/1148862/embla-medical-voksede-pa-toplinjen-men-opkob-og-omstrukturering-kostede
-
Novonesis løftes til "køb" med kursmål 440 kr. hos DNB https://www.proinvestor.com/investornyt/1149401/novonesis-loftes-til-kob-med-kursmal-440-kr-hos-dnb
-
Sedana Medical AB's Interim report January-March 2024
Off to a strong start with record sales in Q1
-
"Coming out of a successful 2023, we have established ambitious goals for 2024: achieving an all-time-high in sales, attaining EBITDA break-even outside of the US within the year, and obtaining top-line data from our U.S. clinical program, which could pave the way to our single biggest growth opportunity.
-
SEDANA MEDICAL COMPLETES PATIENT RECRUITMENT FOR INSPIRE-ICU 1 CLINICAL TRIAL IN THE US
-
Høreapparatproducenter opmærksomme på audiologmangel: Vi arbejder løbende på det https://www.proinvestor.com/investornyt/1150685/horeapparatproducenter-opmaerksomme-pa-audiologmangel-vi-arbejder-lobende-pa-det
-
Coloplast er overbevist om at sårplejeprodukter lever op til nye tilskudskrav i USA https://www.proinvestor.com/investornyt/1150790/coloplast-er-overbevist-om-at-sarplejeprodukter-lever-op-til-nye-tilskudskrav-i-usa
-
Schweizisk GN-konkurrent op efter stærkt regnskab https://www.proinvestor.com/investornyt/1152260/schweizisk-gn-konkurrent-op-efter-staerkt-regnskab
-
GN-rival topper i Zürich efter stærkt regnskab - gaming og headsets trækker op https://www.proinvestor.com/investornyt/1152262/gn-rival-topper-i-zurich-efter-staerkt-regnskab-gaming-og-headsets-traekker-op
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind